| LUC1506 | Cancer of the lung (squamous cell carcinoma) paired with normal, 75 cases (1.1mm), set 6. | 75 Cases (1.1 mm) | Sign In for Pricing | |
| ES1505a | Esophagus squamous cell carcinoma with matched cancer adjacent tissue and esophagus lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/150 cores (core size 1.5mm), replacing ES1505 | 1 Each | Sign In for Pricing | |
| PA2082a | Pancreas cancer with pancreas tissue array, including ductal adenocarcinoma ( PADC) , acinar cell carcinoma ( PACC) , normal adjacent and pancreas tissue, pathology grade, TNM and clinical stage, 96 cases/192 cores ( 1.0mm), replacing PA2082-PA2082a | each | Sign In for Pricing | |
| LC953 | Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue , including TNM, clinical stage, pathology grade and survival data, 30 cases/95 cores, replacing LC952 | 1 Each | Sign In for Pricing | |
| KD808 | Different stages of kidney cancer tissue array, containing metastatic carcinoma, including pathology grade, TNM and clinical stage, 80 cases/80 cores | 1 Each | Sign In for Pricing | |
| ES1505 | Esophagus squamous cell carcinoma with matched cancer adjacent tissue and esophagus lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/150 cores ( core size 1.5mm), replaced by ES1505a-ES1505 | each | Sign In for Pricing | |
| OV901 | Multiple ovary tumor with matched cancer adjacent ovary tissue array, including serous carcinoma，clear cell carcinoma，endometrioid adenocarcinoma, mucinous adenocarcinoma, disgerminoma, yolk sac tumor and sertoli-Leydig cell tumors and mixed germ cell tumor, thology grade, TNM and clinical stage (AJCC 8.0), 76 cases/90 cores (1.5mm) | 1 Each | Sign In for Pricing | |
| LC20815a | Multiple lung cancer tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma is referenced AJCC 8th version), 208 cases/208 cores, replacing LC20815 | 1 Each | Sign In for Pricing | |
| OV1004a | Ovary cancer with ovary tissue array, including high grade serous carcinoma, mixed carcinoma and clear cell carcinoma, mucinous carcinoma, endometrioid carcinoma, pathology grade, TNM and clinical stage (AJCC 8.0), 50 cases/100 cores (core size 1.5mm), replacing OV1004-OV1004a | each | Sign In for Pricing | |
| BR1005b | Breast cancer with matched metastatic carcinoma of lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1005a-BR1005b | each | Sign In for Pricing | |
| ES1041 | Esophagus cancer, cancer adjacent and normal esophagus tissue array, including squamous cell carcinoma, adenocarcinoma, undifferentiated carcinoma, AT and normal tissue, pathology grade, TNM and clinical stage (AJCC 8.0), 104 cases/104 cores (core size 1.5mm) , replacing ES1021-ES1041 | each | Sign In for Pricing | |
| LC1503 | Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma fererence AJCC 8th edition), 75 cases/150 cores, replacing LUC1503-LC1503 | each | Sign In for Pricing | |
| LV483a | Liver cancer and normal liver tissue array, including hepatocellular carcinoma, cholangiocellular carcinoma and normal tissues pathology grade, TNM and clinical stage (AJCC 7th edition), 48 cases/48 cores (core size 1.5mm), replacing LV483 | 1 Each | Sign In for Pricing | |
| LC10012b | Lung non-small cell carcinoma NSCLC tissue array with cancer adjacent lung tissue and normal lung tissue | each | Sign In for Pricing | |
| BL241b | Bladder urothelial carcinoma with matched cancer adjacent bladder tissue array, including TNM and clinical stage, 10 cases/24 cores, replacing BL241a | 1 Each | Sign In for Pricing | |
| T104a | Cervix cancer tissue array, including squamous cell carcinoma, glassy cell carcinoma and adenocarcinoma， pathology grade, TNM and clinical stage, 6 cases/24 cores（1.5mm）, replacing T104 | 1 Each | Sign In for Pricing | |
| LV803a | Liver carcinoma (combination of adjacent normal, cancer and cancer adjacent tissue), including TNM and pathology grade, 54cases/ 72 cores, replaced by LV803b | 1 Each | Sign In for Pricing | |
| BR1008b | Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM, clinical stage, and ER/PR/Her2 result. 100 cases/100 cores, replacing BR1008a-BR1008b | each | Sign In for Pricing | |
| KD603 | Kidney cancer with matched adjacent normal kidney tissue array, containing metastatic clear cell carcinoma, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 33 cases/61 cores | 1 Each | Sign In for Pricing | |
| TP242f | Top 4 types of cancer (colon, breast, lung and prosate) with normal tissue array, including colon adenocarcinoma, breast invasive carcinoma of no special type, prostate adenocarcinoma, lung squamous cell carcinoma, lung adenocarcinoma, grade, TNM and clinical state (AJCC 8.0), 24 cases/24 cores (core size 1.5mm) ，replacing TP242e，Recent Year Collection | 1 Each | Sign In for Pricing | |
| BRM961a | Breast cancer with matched metastatic carcinoma or breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 49 cases/96 cores-BRM961a | each | Sign In for Pricing | |
| LV8011b | Liver disease spectrum (hepatic cancer progression) and liver tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 77 cases/80 cores, replacing LV8011a | 1 Each | Sign In for Pricing | |
| PA721a | Pancreatic cancer tissue array with normal pancreatic tissue, including duct adenocarcinoma (PADC) and islet cell carcinoma, TNM and pathology grade, 24 cases/96 cores (core size 1.5mm), replacing PA721 | 1 Each | Sign In for Pricing | |
| CO992b | Colorectal cancer with matched lymph node metastasis carcinoma and normal adjacent or cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 43 cases/99 cores (1.5mm), replacing CO992a-CO992b | each | Sign In for Pricing | |
| KD951a | Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma | each | Sign In for Pricing | |
| LC10016 | Non-small cell lung carcinoma (NSCLC) with matched cancer adjacent lung tissue array, including TNM, clinical stage (AJCC 8th edition) and pathology grade, 50 cases/100 cores (core size 1.0mm), replacing LC10012b, recent years sample collection. | 1 Each | Sign In for Pricing | |
| MBS6486234-01 | MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (FITC) | 0.2 mL | Sign In for Pricing | |
| MBS6486234-02 | MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (FITC) | 5x 0.2 mL | Sign In for Pricing | |
| MBS6486237-01 | MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 490) | 0.1 mL | Sign In for Pricing | |
| MBS6486237-02 | MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 490) | 5x 0.1 mL | Sign In for Pricing | |
| MBS6486238-01 | MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 550) | 0.1 mL | Sign In for Pricing | |
| MBS6486238-02 | MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 550) | 5x 0.1 mL | Sign In for Pricing | |
| MBS6486240-01 | MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 750) | 0.1 mL | Sign In for Pricing | |
| MBS6486240-02 | MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 750) | 5x 0.1 mL | Sign In for Pricing | |
| MBS6401307-01 | MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass | 0.1 mL | Sign In for Pricing | |
| MBS6401307-02 | MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass | 5x 0.1 mL | Sign In for Pricing | |
| MBS6401316-01 | MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass | 0.1 mL | Sign In for Pricing | |
| MBS6401316-02 | MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass | 5x 0.1 mL | Sign In for Pricing | |
| MBS644652-01 | DIRC2, ID (DIRC2, Disrupted in renal carcinoma protein 2, Disrupted in renal cancer protein 2) | 0.2 mL | Sign In for Pricing | |
| MBS644652-02 | DIRC2, ID (DIRC2, Disrupted in renal carcinoma protein 2, Disrupted in renal cancer protein 2) | 5x 0.2 mL | Sign In for Pricing | |
| CAF07-S | Human Lung Squamous Cell Carcinoma Cancer-Associated Fibroblasts (CAFs) | 1000000 Cells | Sign In for Pricing | |
| MBS6151407-01 | BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (HRP) | 0.1 mL | Sign In for Pricing | |
| MBS6151407-02 | BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (HRP) | 5x 0.1 mL | Sign In for Pricing | |
| MBS6142792-01 | MAGED2 (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (Biotin) | 0.1 mL | Sign In for Pricing | |
| MBS6142792-02 | MAGED2 (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (Biotin) | 5x 0.1 mL | Sign In for Pricing | |
| MBS6191049-01 | MAGED2 (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 405) | 0.1 mL | Sign In for Pricing | |
| MBS6191049-02 | MAGED2 (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 405) | 5x 0.1 mL | Sign In for Pricing | |
| MBS6007290-01 | MAGED2 (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) | 0.1 mg | Sign In for Pricing | |
| MBS6007290-02 | MAGED2 (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) | 5x 0.1 mg | Sign In for Pricing | |
| MBS6130195-01 | BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (AP) | 0.1 mL | Sign In for Pricing | |